Alnylam Pharmaceuticals | Utile Per Azione



Fiscal Calendario Efettivo Consenso Precedente Data
FY2025Q1 Mar/2025 -0.9386 -0.16 May/01 2025
FY2024Q4 Dec/2024 0.06 -0.58 -0.77 Feb/13 2025
FY2024Q3 Sep/2024 -0.50 -0.93 1.74 Oct/31 2024
FY2024Q2 Jun/2024 0.56 -1.05 -2.21 Aug/01 2024
FY2024Q1 Mar/2024 -0.16 -1.14 -1.4 May/02 2024
FY2023Q4 Dec/2023 -0.77 -1.26 -1.68 Feb/15 2024
FY2023Q3 Sep/2023 1.74 -1.32 -2.69 Nov/02 2023
FY2023Q2 Jun/2023 -2.21 -1.50 -2.29 Aug/03 2023
FY2023Q1 Mar/2023 -1.4 -1.79 -2.00 May/04 2023
FY2022Q4 Dec/2022 -1.68 -1.95 -2.16 Feb/23 2023
FY2022Q3 Sep/2022 -2.69 -1.79 -1.64 Oct/27 2022
FY2022Q2 Jun/2022 -2.29 -1.63 -1.61 Jul/28 2022

Eps Cambiamento Data
Acadia Pharmaceuticals USD 0.86 0.66 2024-12
Agios Pharmaceuticals USD -1.44 0.98 2024-12
Alnylam Pharmaceuticals USD -0.65 0.22 2024-12
Amgen USD 5.31 0.27 2024-12
Arrowhead Research USD -1.39 0.02 2024-12
BioMarin Pharmaceutical USD 0.64 0.09 2024-12
Incyte USD 1.43 0.36 2024-12
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
Moderna USD -2.91 2.94 2024-12
Neurocrine Biosciences USD 1 0.24 2024-12
Novartis USD 1.98 0.08 2024-12
PTC Therapeutics USD -2.15 0.76 2024-12
Regeneron Pharmaceuticals USD 12.07 0.39 2024-12
Sanofi USD 0.7 0.87 2024-12
Sarepta Therapeutics USD 1.5 1.16 2024-12
Takeda JPY 15.15 42.99 2024-12
Tectonic Therapeutic USD -1.2 3.14 2024-09
Ultragenyx Pharmaceutical USD -1.39 0.01 2024-12
Vertex Pharmaceuticals USD 3.98 0.4 2024-12
Xencor USD -0.62 0.09 2024-12



Alnylam Pharmaceuticals Utile Per Azione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.